Literature DB >> 6584874

Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.

C O Jacob, M Sela, R Arnon.   

Abstract

Six peptides corresponding to various segments of the B subunit of cholera toxin have been synthesized and covalently linked to tetanus toxoid. Of the antibodies raised in rabbits against these conjugates, four crossreacted to different extents with the intact B subunit and whole native cholera toxin. Antisera to the peptide of sequence 75-85 were not crossreactive, whereas elongation by six amino acid residues resulted in a peptide (69-85) leading to antibodies crossreactive with the cholera toxin. Of most interest was peptide CTP3 (50-64), which was the only one that reacted with antisera to cholera toxin and which led to antibodies reacting with the cholera toxin to a similar level as its homologous peptide-antipeptide reaction. Indeed, antisera to CTP3 neutralized significantly the biological activity of cholera toxin, as followed by skin vascular permeability and by fluid accumulation in ligated small intestinal loops of rabbits.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6584874      PMCID: PMC534390          DOI: 10.1073/pnas.80.24.7611

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Studies on the chemical basis of the antigenicity of proteins. 2. Antigenic specificity of polytyrosyl gelatins.

Authors:  R ARNON; M SELA
Journal:  Biochem J       Date:  1960-04       Impact factor: 3.857

Review 2.  Automated synthesis of peptides.

Authors:  R B Merrifield
Journal:  Science       Date:  1965-10-08       Impact factor: 47.728

3.  Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein, the hepatitis B surface antigen.

Authors:  A R Neurath; S B Kent; N Strick
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

4.  Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence.

Authors:  J L Bittle; R A Houghten; H Alexander; T M Shinnick; J G Sutcliffe; R A Lerner; D J Rowlands; F Brown
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

5.  Successful immunization with a totally synthetic diphtheria vaccine.

Authors:  F Audibert; M Jolivet; L Chedid; R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Anti-influenza response achieved by immunization with a synthetic conjugate.

Authors:  G M Müller; M Shapira; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.

Authors:  A M Prince; H Ikram; T P Hopp
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

8.  Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.

Authors:  P K Bhatnagar; E Papas; H E Blum; D R Milich; D Nitecki; M J Karels; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

9.  Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees.

Authors:  J L Gerin; H Alexander; J W Shih; R H Purcell; G Dapolito; R Engle; N Green; J G Sutcliffe; T M Shinnick; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

10.  Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.

Authors:  E Pfaff; M Mussgay; H O Böhm; G E Schulz; H Schaller
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  19 in total

1.  Monoclonal B-cell response to diphtheria toxoid: evidence for cross-reactive epitopes.

Authors:  B Autran; F Triebel; M Viguier; M Jolivet; P Falmagne; P Debre
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

2.  Probing into the realm of proteins and immunity.

Authors:  M Sela
Journal:  Protein Sci       Date:  1998-07       Impact factor: 6.725

3.  Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein D.

Authors:  H J Geerligs; M Feijlbrief; M Bolk; C A Bos; J W Drijfhout; G W Welling; S Welling-Wester
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity.

Authors:  I Harari; A Donohue-Rolfe; G Keusch; R Arnon
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

5.  Immunogenicity of cholera toxin B epitope inserted in Salmonella flagellin expressed on bacteria and administered as DNA vaccine.

Authors:  Neeraj Chauhan; Ravindra Kumar; Jitendra Badhai; Anju Preet; Pramod Kumar Yadava
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

6.  Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides.

Authors:  C O Jacob; M Sela; M Pines; S Hurwitz; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

Review 7.  Fimbriae-assisted bacterial surface display of heterologous peptides.

Authors:  P Klemm; M A Schembri
Journal:  Int J Med Microbiol       Date:  2000-07       Impact factor: 3.473

8.  Study of epitopes of cholera enterotoxin-related enterotoxins by checkerboard immunoblotting.

Authors:  M Kazemi; R A Finkelstein
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

9.  Induction of rat secretory IgA antibodies against cholera toxin by a synthetic peptide.

Authors:  C O Jacob; J P Vaerman
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

10.  A 20-kilodalton N-terminal fragment of the D15 protein contains a protective epitope(s) against Haemophilus influenzae type a and type b.

Authors:  Y p Yang; W R Thomas; P Chong; S M Loosmore; M H Klein
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.